Nonadherence to asthma treatment and failure of therapy

Current Opinion in Pediatrics

Volumn 9, Issue 6, 1997, Pages 590-595

  Milgrom, Henry ^a   Bender, Bruce ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT;

ASTHMA; ETHNOLOGY; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; LUNG FUNCTION; MEDICAL DECISION MAKING; MENTAL DISEASE; MORBIDITY; MORTALITY; NEGRO; PATIENT COMPLIANCE; PATIENT MONITORING; POVERTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; URBAN AREA;

EID: 0031464112     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199712000-00008     Document Type: Review

References (58)

1. Urquhart J: Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J 1996, 17:8-15. Thoughtful analysis of practical points that have only come to light with the use of electronic monitoring of adherence.
2. Larkin M: Non-compliance worsens children's asthma. Lancet 1997, 349:185.
3. National Asthma Education and Prevention Program: Highlights of the Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. [Publication No. 97-4051A]. Bethesda, MD: United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1997. Basic recommendations for the diagnosis and management of asthma to help clinicians and patients make appropriate decisions.
4. National Asthma Education and Prevention Program: Executive Summary: Guidelines for the Diagnosis and Management of Asthma. [Publication No. 91-3042] Bethesda, MD: United States Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1991.
5. Redline S, Wright EC, Kattan M, Kercsmar C, Weiss K: Short-term compliance with peak flow monitoring: results from a study of inner city children with asthma. Pediatr Pulmonol 1996, 21:203-210.
6. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C: Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996, 98:1051-1057.
7. Toogood JH: High-dose inhaled steroid therapy for asthma. J Allergy Clin Immunol 1989, 83:528-536.
8. Lipworth B: Airway and systemic effects of inhaled corticosteroids in asthma. Pulm Pharmacol 1996, 9:19-27.
9. Urquhart J: How much compliance is enough? Pharm Res 1996, 13:10-11. Considers the influence of noncompliance on standard dosing regimens.
10. Creer TL, Wigal JK: Self-efficacy. Chest 1993, 103:1316-1317.
11. Gibson NA, Ferguson AE, Aitchison TC, Paton JY: Compliance with inhaled asthma medication in preschool children. Thorax 1995, 50:1274-1279.
12. Hatton MQ, Allen MB, Vathenen SV, Feely MP, Cooke NJ: Compliance with oral corticosteroids during steroid trials in chronic airways obstruction. Thorax 1996, 51:323-324.
13. Rand CS, Wise RA: Adherence with asthma therapy in the management of asthma: review and clinical guidelines. In Severe Asthma: Pathogenesis and Clinical Management. Edited by Szefler SJ, Leung DYM. New York: Marcel Dekker; 1995:435-464.
14. Matsui D: Drug compliance in pediatrics: clinical and research issues. Pediatr Clin North Am 1997, 44:1-14. Comprehensive review of adherence by pediatric patients.
15. Pedersen S: Inhalers and nebulizers: which to choose and why. Respir Med 1996, 90:69-77. Overview of the types of inhalers available, and the factors to be considered, including ease of use and patient age, in recommending one device over another.
16. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R: Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997, 277:887-891. This study validates the recommendations of the Expert Panel [3••] by showing that the use of inhaled corticosteroids and cromolyn is associated with a significant decrease in hospitalization for asthma.
17. Hartert TV, Windom HH, Peebles RS: Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996, 100:386-394. This study documents multiple problems in conforming with the standards of care advocated by the NAEPP. In a population of innercity patients with moderate to severe asthma, management was characterized by underutilization of anti-inflammatory therapy and overutilization of β-agonists, inability to use inhalation devices properly, inadequate communication between patient and physician, lack of an action plan to be utilized in the event of an acute exacerbation, and inadequate physician intervention during the acute stages of the exacerbation.
18. Beausoleil J, Weldon D, McGeady S: β2-agonist metered dose inhaler overuse: psychological and demographic profiles. Pediatrics 1997, 99:40-43.
19. Finkelstein JA, Brown RW, Schneider LC, Weiss ST, Quintana JM, Goldmann DA, Homer CJ: Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics 1995, 95:389-394.
20. Brooks CM, Richards JM, Kohler CL, Soong SJ, Martin B, Windsor RA, Bailey WC: Integrating guidelines with continuous quality improvement: doing the right thing the right way to achieve the right goals. Jt Comm J Qual Improv 1994, 20:181-191.
21. Greineder DK: Adaptation of asthma practice guidelines into clinical care: the Harvard Pilgrim Health Care experience. J Outcomes Mangmt 1996, 3:4-9.
22. Lang D, Sherman M, Polansky M: Guidelines and realities of asthma management: the Philadelphia story. Arch Intern Med 1997, 157:1193-1200.
23. Lasagna L, Hutt P: Health care research, and regulatory impact of noncompliance. In Patient Compliance in Medical Practice and Clinical Trials. Edited by Cramer J, Spilker B. New York: Raven Press; 1991:393-403.
24. Matsuyama JR, Mason BJ, Jue SG: Pharmacists' interventions using an electronic medication-event device's adherence data versus pill counts. Ann Pharmacother 1993, 27:851-855.
25. Gerbino P: Forward. Ann Pharmacother 1993, 27:83-4.
26. Lang DM: Trends in US asthma mortality: good news and bad news. Ann Allergy Asthma Immunol 1997, 78:333-337.
27. Centers for Disease Control and Prevention: Asthma mortality and hospitalization among children and young adults, United States, 1990-1993. MMWR 1996, 45:350-353.
28. Sly RM, O'Donnell R: Stabilization of asthma mortality. Ann Allergy Asthma Immunol 1997, 78:347-354. Reports and comments on annual rates of asthma mortality in the United States in the 1990s.
29. Pierce PF: When the patient chooses: describing unaided decisions in health care. Hum Factors 1996, 38:278-287.
30. Obias-Manno D, Friedmann E, Brooks MM, Thomas SA, Haakenson C, Morris M, Wimbush F, Somelofski C, Goldner F: Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST). Ann Epidemiol 1996, 6:93-101. In this study active medication led to increased mortality. A 10% increase in adherence led to more than a threefold increase in risk of death caused by arrhythmia.
31. Partridge M: Communication and asthma. Monaldi Arch Chest Dis 1994, 49:98-100.
32. Harris LE, Luft FC, Rudy DW, Tierney WM: Correlates of health care satisfaction in inner-city patients with hypertension and chronic renal Insufficiency. Soc Sci Med 1995, 41:1639-1645.
33. Spilker B: Methods of assessing and improving patient compliance in clinical trials. In Patient Compliance in Medical Practice and Clinical Trials. Edited by Cramer J, Spilker B. New York: Raven Press; 1991:37-56.
34. Coutts JA, Gibson NA, Paton JY: Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992, 67:332-333.
35. Blackwell B: Drug therapy: patient compliance. N Engl J Med 1973, 289:249-252.
36. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP: Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996, 15:631-645.
37. Bender B, Milgrom H: Compliance with asthma therapy: a case for shared responsibility. J Asthma 1996, 33:199-202.
38. True WR, Romeis JC, Heath AC, Flick LH, Shaw L, Eisen SA, Goldberg J, Lyons MJ: Genetic and environmental contributions to healthcare need and utilization: a twin analysis. Health Serv Res 1997, 32:37-53.
39. Bender B, Milgrom H, Rand C, Ackerson L: Psychological factors associated with medication nonadherence in asthmatic children. J Asthma 1997, in press.
40. Bosley C, Fosbury J, Cochrane G: The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995, 8:899-904.
41. Strunk RC: Asthma deaths in childhood: identification of patients at risk and intervention. J Allergy Clin Immunol 1987:472-477.
42. Haynes R, McKibbon K, Kanani R: Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996, 348:383-386. The authors reviewed 252 articles reporting the results of interventions designed to help patients adhere to therapy. Only 13 met the following minimum criteria: randomized controlled trial, one or more measure of adherence with prescribed medication, one or more measure of treatment outcome, and at least 80% follow-up. Seven studies were associated with improvement in adherence, and six led to improvement in treatment outcome. However, even the most effective interventions did not lead to substantial improvement.
43. Blessing-Moore J: Does asthma education change behavior? To know Is not to do. Chest 1996, 109:9-19.
44. Bernard-Bonnin A, Stachenko S, Bonin D, Charette C, Rousseau E: Self management teaching programs and morbidity of pediatric asthma: A meta-analysis. J Allergy Clin Immunol 1995, 95:529-540.
45. Kolbe J, Vamos M, James F, Elkind G, Garrett J: Assessment of practical knowledge of self-management of acute asthma. Chest 1996, 109:86-90.
46. Roberson M: The meaning of compliance: patient perspectives. Qual Health Res 1992, 2:7-26.
47. Johnson T: Managing patients. Fam Med 1995, 27:460-463.
48. Butler C, Rollnick S, Stott N: The practioner, the patient and resistance to change: recent ideas on compliance. Can Med Assoc J 1996, 154:1357-1362.
49. Laine C, Davidoff F, Lewis CE, Nelson EC, Nelson E, Kessler RC, Delbanco TL: Important elements of outpatient care: a comparison of patients' and physicians' opinions. Ann Intern Med 1996, 125:640-645.
50. Kravitz RL, Callahan EJ, Paterniti D, Antonius D, Dunham M, Lewis CE: Prevalence and sources of patients' unmet expectations for care. Ann Intern Med 1996, 125:730-737.
51. Feinstein AR: Twentieth century paradigms that threaten both scientific and humane medicine in the twenty-first century. J Clin Epidemiol 1996, 49:615-617. Professor Feinstein contributed this essay to an issue of the Journal of Clinical Epidemiology honoring Petr Skrabanek. The author writes, "According to Skrabanek, humane medicine itself is being threatened, not just by erroneous scientific ideas about etiology and therapy, but by 'coercive healthism'." He warns that physicians may be transformed from their traditional role of personal concern and individual care to new activities that involve uninvited intrusion and zealous advocacy and new roles as bureaucratic custodians of public health.
52. Savulescu J: Rational non-interventional paternalism: why doctors ought to make judgments of what is best for their patients. J Med Ethics 1995, 21:327-331.
53. Courtney R, Ballard E, Fauver S, Gariota M, Holland L: The partnership model: working with individuals, families, and communities toward a new vision of health. Public Health Nurs 1996, 13:177-186.
54. Deber RB, Kraetschmer N, Irvine J: What role do patients wish to play in treatment decision making? Arch Intern Med 1996, 156:1414-1420.
55. Quill TE, Brody H: Physician recommendations and patient autonomy: finding a balance between physician power and patient choice. Ann Intern Med 1996, 125:763-769.
56. Anie KA, Jones PW, Hilton SR, Anderson HR: A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma. J Clin Epidemiol 1996, 49:653-656.
57. Greineder D, Loane K, Parks P: Reduction in resource utilization by an asthma outreach program. Arch Pediatr Adolesc Med 1995, 149:415-420.
58. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP: Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996, 109:963-968.